Home >> Tag Archives: Genomic Health—

Tag Archives: Genomic Health—

Idylla IVD Oncotype DX test in development

Sept. 27, 2017—Genomic Health and Biocartis Group announced an exclusive agreement to develop an in vitro diagnostic version of the Oncotype DX Breast Recurrence Score test on Biocartis’ Idylla platform that can be performed locally by laboratory partners and in hospitals around the world. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s ...

Read More »

Genomic Health, Epic Sciences collaboration, 9/16

September 2016—Genomic Health and Epic Sciences announced an exclusive agreement to commercialize Epic Sciences’ novel AR-V7 liquid biopsy test in the U.S. through Genomic Health’s commercial channel. The blood-based test detects the V7 variant of the androgen receptor protein in the nucleus of circulating tumor cells—information that can help guide treatment selection in patients with metastatic castration-resistant prostate cancer.

Read More »
X